Estimating blood donor loss due to the variant CJD travel deferral

Transfusion

Volumn 44, Issue 5, 2004, Pages 645-650

  Murphy, Edward L ^a   Connor, J David ^b   McEvoy, Patrick ^b   Hirschler, Nora ^b   Busch, Michael P ^b   Roberts, Paula ^b   Nguyen, Kim Ank ^b   Reich, Pascale ^b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARMY; BLOOD DONOR; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; FEMALE; FOOD AND DRUG ADMINISTRATION; GEOGRAPHY; HEALTH CARE POLICY; HEALTH CENTER; HUMAN; HUMAN EXPERIMENT; LOGISTIC REGRESSION ANALYSIS; MALE; NORMAL HUMAN; QUESTIONNAIRE; REVIEW; SELF EVALUATION; SEX RATIO; STATISTICAL ANALYSIS; TRAVEL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD DONORS; CREUTZFELDT-JAKOB SYNDROME; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; SEX FACTORS; TRAVEL;

EID: 2342604378     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03307.x     Document Type: Review

References (20)

1. Turner ML, Ludlam CA. Variant Creutzfeldt-Jakob disease. Transfus Med Rev 2000;14:216-22.
2. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003;289:959-62.
3. Foster PR. Prions and blood products. Ann Med 2000;32:501-13.
4. Brown P. Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin Hematol 1995;2:472-7.
5. Ricketts MN. Is Creutzfeldt-Jakob disease transmitted in blood? Is the absence of evidence of risk evidence of the absence of risk? Can Med Assoc J 1997;157:1367-70.
6. Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994;343:298-9.
7. Esmonde TF, Will RG, Slattery JM, et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993;341:205-7.
8. Contreras M, Barbara J, Hewitt P. Creutzfeldt-Jakob disease and blood transfusion. Br Med J 1991;303:187-8.
9. Watkins AM. Creutzfeldt-Jakob disease and blood transfusion. Br Med J 1991;302:1537.
10. Hunter N, Houston F. Can prion diseases be transmitted between individuals via blood transfusion: evidence from sheep experiments. Dev Biol (Basel) 2002;108:93-8.
11. Dodd RY, Busch MP. Animal models of bovine spongiform encephalopathy and vCJD infectivity in blood: two swallows do not a summer make. Transfusion 2002;42:509-12.
12. Brown P. Variant CJD transmission through blood: risks to predictors and "predictees." Transfusion 2003;43:425-7.
13. Kaye D. FDA seeks tighter rules on blood donors. Clin Infect Dis 2001;33:i.
14. Ramsay S, Birchard K, Watts J. Variant CJD fears prompt growing number of countries to ban British blood donations. Lancet 1999;354:754.
15. Wilson K, Hebert PC, Laupacis A, et al. A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and the blood supply. Can Med Assoc J 2001;165:59-65.
16. Reynolds E, Wickenden C, Oliver A. The impact of improved safety on maintaining a sufficient blood supply. Transfus Clin Biol 2001;8:235-9.
17. US Food and Drug Administration. Guidance for industry. Revised preventive measures to reduce the possible risk of transmission of Creutzfeld-Jakob disease (CJD) and variant Creutzfeld-Jakob disease (vCJD) by blood and blood products. January, 2002. http://www.fda.gov/cber/gdlns/cjdvcjd.pdf.
18. US Food and Drug Administration, Center for Biologies Evaluation and Research. Transmissible Spongiform Encephalopathies Advisory Committee transcript, June 28, 2001. http://www.fda.gov/ohrms/dockets/ac/cber01.htm.
19. Centers for Disease Control. Epi Info Software, version 2002. http://www.cdc.gov/epiinfo.
20. US Food and Drug Administration. TSEAC transcripts, January 18-19, 2001. http://www.fda.gov/ohrms/dockets/ac/cber01.htm.